Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
Adjusting medications containing controlled substances due to drug shortages
August 5, 2025
Important factors for pharmacy teams to consider when navigating controlled substance shortages.
Read more ➞
